USPTO serial 88479681
LOX-INDEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 2, 2020
- Examiner
- TOY, JOSHUA SPENCER JOLL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with LOX-INDEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Minato-ku, Tokyo, JP
MINATO-KU, TOKYO, JP
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic biomarker reagents for medical purposes; Medical diagnostic reagents and assays for testing of blood samples taken from patients; Diagnostic reagents for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing blood samples taken from patients; Diagnostic kits comprising diagnostic agents, preparations and substances for medical use; Diagnostic biomarker reagents for medicinal use in the field of arteriosclerosis risk; Diagnostic biomarker reagents for medicinal use in the field of risk of heart diseases; Diagnostic biomarker reagents for medicinal use in the field of risk of cerebral diseases; Diagnostic biomarker reagents for medicinal use in the field of risk of a cerebral and a myocardial infarction; Diagnostic reagents for medicinal use in the field of arteriosclerosis; Diagnostic reagents for medicinal use in the field of heart diseases; Diagnostic reagents for medicinal use in the field of cerebral diseases; Diagnostic reagents for medicinal use in the field of a cerebral infarction and a myocardial infarction | ACTIVE | — |
| 042 | Scientific research services for medical purpose; Scientific research for medical purposes in the area of cerebral infarction; Scientific research for medical purposes in the area of myocardial infarction; Scientific research for medical purposes in the area of cerebrovascular diseases; Scientific research for medical purposes in the area of heart diseases; Scientific research for medical purposes in the area of arteriosclerosis; Design and development of medical technology in the field of surgical robots; Research and development in the field of diagnostic preparations; Testing of pharmaceuticals; Scientific and medical research and development in the field of pharmaceuticals; Consultancy relating to pharmaceutical research and development; Research on the subject of pharmaceuticals; Development of pharmaceutical preparations and medicines; Design and development of medical diagnostic apparatus; Medical research; Biotechnology research; Conducting technical project studies in the nature of scientific feasibility studies; Scientific laboratory services; Scientific research; Technological research in the field of medical instruments; Design and development of computer hardware and software for medical technology for use in the field of medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 2, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 8, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 8, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 8, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 8, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 8, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 2, 2020 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Apr 28, 2020 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 21, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 13, 2020 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Apr 13, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 13, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 13, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 13, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 13, 2020 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 7, 2020 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Apr 7, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 7, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 7, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 7, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 23, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 23, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 20, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 12, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 12, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 12, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 12, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 29, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 22, 2019 | NWAP | NEW APPLICATION ENTERED | — |